Twelve stories above New Haven Harbor, BioXcel Therapeutics is using Big Data technology to mine Big Pharma chemistry and create new drugs that treat pancreatic cancer and some of the symptoms of Alzheimer’s Disease, schizophrenia, and delirium.
BioXcel Therapeutics is a publicly-traded spin-off of the Branford-based data analytics company BioXcel Corporation, which specializes in using Artificial Intelligence (AI) to create new medicines in the realms of neuroscience and immuno-oncology.